The effect of an ADL orientated practical activation of demented persons in a home setting by informed caregivers and cognitiv activation by external personal in a home setting- a multicenter, randomised controlled trial for the evaluation of a multimodal, manual based and tailor-made activation programme.

The effect of an ADL orientated practical activation of demented persons in a home setting by informed caregivers and cognitiv activation by external personal in a home setting- a multicenter, randomised controlled trial for the evaluation of a multimodal, manual based and tailor-made activation programme. - ANAA+KO

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00000395

Enrollment

117

Registered

2010-05-11

Start date

2009-12-15

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00

Interventions

Group 1: ADL based practical activation by an informed caregiver and cognitive activation by an externally personal in a home setting. The informed caregiver will take over the ADL based practical act

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosed Alzheimer's disease according to the criterias of ICD-10/ DSM IV Screeninginstruments are Mini-Mental-State-Examination (Score: >=12 and <=24), SIDAM + integrated HIS. (live with an informed caregiver)

Exclusion criteria

Exclusion criteria: Diagnosed vascular dementia according to the criterias of ICD-10/DSM IV. Disagreed score of screening instruments. Reluctance of the informed caregiver to take over the practical activation, no possibility of activation because of disabilities, no compliance, excessive consumation of alcohol, drugs or medications, neurological or psychiatric diseases such as depressions, schizophrenia.

Design outcomes

Primary

Measure	Time frame
First measuring point (t0 after screening) and second measuring point (t1) after an intervention period of 6 month. Third measuring point (t2) after 12 month: Measuring of ADL- abitities (E-ADL-Test) and cognitive abitities (ADAS-cog-Test) for the patients.	—

Secondary

Measure	Time frame
First measuring point (t0 after screening) and second measuring point (t1) after an intervention period of 6 month. Third measuring point (t2) after 12 month: Measuring of extent of care dependency by use of scale (PAS) and geriatric symptoms included instrumental function abilities (questionnaire: NOSGER-scale) for the patients, quality of life (questionnaire:WHOQol-BREF) and strain for the informed caregivers (questionnaire:HPS)	—

Measure

Time frame

First measuring point (t0 after screening) and second measuring point (t1) after an intervention period of 6 month. Third measuring point (t2) after 12 month: Measuring of extent of care dependency by use of scale (PAS) and geriatric symptoms included instrumental function abilities (questionnaire: NOSGER-scale) for the patients, quality of life (questionnaire:WHOQol-BREF) and strain for the informed caregivers (questionnaire:HPS)

—

Countries

Germany

Contacts

Public ContactEva Quack

Katholische Hochschule Mainz

quack@kfh-mainz.de06131/2894472

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026